Main B‐cell epitopes of PvAMA‐1 and PvMSP‐9 are targeted by naturally acquired antibodies and epitope‐specific memory cells in acute and convalescent phases of vivax malaria
Autor: | Kézia K. G. Scopel, Rodrigo Nunes Rodrigues-da-Silva, Clovis R. Nakaie, Josué da Costa Lima-Junior, Roberta Reis Soares, Rogério Lauria da Silva |
---|---|
Rok vydání: | 2020 |
Předmět: |
0301 basic medicine
030231 tropical medicine Immunology Plasmodium vivax Protozoan Proteins Antibodies Protozoan Antigens Protozoan Epitope 03 medical and health sciences 0302 clinical medicine Immunity Malaria Vivax medicine Humans Memory B cell B-Lymphocytes biology Apical membrane biology.organism_classification medicine.disease Immunity Humoral 030104 developmental biology Immunoglobulin G Humoral immunity biology.protein Epitopes B-Lymphocyte Parasitology Antibody Peptides Immunologic Memory Brazil Malaria |
Zdroj: | Parasite Immunology. 42 |
ISSN: | 1365-3024 0141-9838 |
Popis: | Although antibodies are considered critical for malaria protection, little is known about the mechanisms/factors that maintain humoral immunity, especially regarding the induction and maintenance of memory B cells over time. In Brazilian endemic areas, this is the first time that the profile of antibody responses and the occurrence of antigen-specific memory B cells (MBC) against P vivax were investigated during acute malaria and up to six months after parasite clearance. For this, we selected two peptides, PvAMA-1(S290-K307) and PvMSP-9(E795-A808) , which represent the apical membrane antigen-1 and merozoite surface protein-9 of P vivax, respectively. Both peptides were previously described as containing linear B-cell epitopes. Our findings were as follows: 1-both peptides were recognized by IgG antibodies at a high frequency (between 24% and 81%) in all study groups; 2-in the absence of infection, the IgG levels remained stable throughout 6 months of follow-up; and 3-PvAMA-1(S290-K307) and PvMSP-9(E795-A808) -specific MBCs were detected in all individual groups in the absence of reinfection throughout the follow-up period, suggesting long-lived MBC. However, no positive association was observed between malaria-specific antibody levels and frequency of MBCs over time. Taken together, these results suggest that peptides can be, in the future, an alternative strategy to polypeptidic vaccine formulation. |
Databáze: | OpenAIRE |
Externí odkaz: |